Similarly to CK18, the clinical utility is feeble for the NASH score that relies on the Patatin-like phospholipase domain-containing protein 3 (PNPLA3) genotype or tests for microRNA profiling [29]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatohepatitis.